We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$28.6B
AUM Growth
-$18.3M
Cap. Flow
-$1.63B
Cap. Flow %
-5.69%
Top 10 Hldgs %
43.66%
Holding
291
New
10
Increased
60
Reduced
140
Closed
13

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$45.6M
2
AZN icon
AstraZeneca
AZN
+$37.9M
3
EOG icon
EOG Resources
EOG
+$23.4M
4
UNH icon
UnitedHealth
UNH
+$20.1M
5
LLY icon
Eli Lilly
LLY
+$14.2M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$152M
2
PG icon
Procter & Gamble
PG
+$129M
3
BNY
Bank of New York Mellon
BNY
+$128M
4
AAPL icon
Apple
AAPL
+$123M
5
CVX icon
Chevron
CVX
+$112M

Sector Composition

Rank Sector Weight
1 Technology 25.27%
2 Financials 17.16%
3 Consumer Staples 16.61%
4 Energy 11.67%
5 Healthcare 11.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YUMC icon
251
Yum China
YUMC
$16.5B
$281K ﹤0.01%
4,980
BSX icon
252
Boston Scientific
BSX
$69.5B
$276K ﹤0.01%
+5,108
New +$267K
QUAL icon
253
iShares MSCI USA Quality Factor ETF
QUAL
$47B
$274K ﹤0.01%
+2,029
New +$258K
DG icon
254
Dollar General
DG
$28B
$266K ﹤0.01%
1,568
ENB icon
255
Enbridge
ENB
$119B
$257K ﹤0.01%
6,917
IWO icon
256
iShares Russell 2000 Growth ETF
IWO
$14.6B
$255K ﹤0.01%
1,051
+137
+15% +$31.4K
HPQ icon
257
HP
HPQ
$24.9B
$251K ﹤0.01%
8,180
WLKP icon
258
Westlake Chemical Partners
WLKP
$763M
$249K ﹤0.01%
11,500
PYPL icon
259
PayPal
PYPL
$48.9B
$249K ﹤0.01%
3,726
-21
-0.6% -$1.43K
NWSA icon
260
News Corp Class A
NWSA
$14.9B
$244K ﹤0.01%
12,535
-2,049
-14% -$37.2K
BRKR icon
261
Bruker
BRKR
$9.57B
$243K ﹤0.01%
3,290
FBIN icon
262
Fortune Brands Innovations
FBIN
$5.88B
$239K ﹤0.01%
3,316
-405
-11% -$25.8K
BP icon
263
BP
BP
$116B
$238K ﹤0.01%
6,758
+1,041
+18% +$38.5K
ROP icon
264
Roper Technologies
ROP
$38.8B
$237K ﹤0.01%
492
-6
-1% -$2.72K
MTR
265
Mesa Royalty Trust
MTR
$5.4M
$234K ﹤0.01%
+9,500
New +$205K
HHH icon
266
Howard Hughes
HHH
$3.81B
$231K ﹤0.01%
3,075
AIG icon
267
American International
AIG
$41.7B
$224K ﹤0.01%
3,892
-403
-9% -$21.6K
URI icon
268
United Rentals
URI
$67.2B
$223K ﹤0.01%
+500
New +$185K
IJJ icon
269
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.91B
$221K ﹤0.01%
2,060
SNOW icon
270
Snowflake
SNOW
$102B
$220K ﹤0.01%
+1,250
New +$203K
MNST icon
271
Monster Beverage
MNST
$94.3B
$218K ﹤0.01%
3,798
MET icon
272
MetLife
MET
$61.9B
$217K ﹤0.01%
3,830
-5,949
-61% -$330K
PXD
273
DELISTED
Pioneer Natural Resource Co.
PXD
$216K ﹤0.01%
1,041
KHC icon
274
Kraft Heinz
KHC
$30.7B
$202K ﹤0.01%
5,684
-950
-14% -$36.5K
IFF icon
275
International Flavors & Fragrances
IFF
$20.2B
$201K ﹤0.01%
2,530
-23,108
-90% -$1.99M

Similar funds

Fayez Sarofim & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Fayez Sarofim & Co held 291 positions worth $28.6B, down 0.06% from $28.6B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Fayez Sarofim & Co withdrew a net $1.63B in Q2 2023, closing 13 positions and reducing 140 holdings. Its most notable exit was AvalonBay Communities, an estimated $1.33M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Staples.

Against the trend, Fayez Sarofim & Co opened a new position in iShares Core High Dividend ETF worth $8.67M.

  • Fayez Sarofim & Co's largest Q2 2023 buy was iShares Core High Dividend ETF: 430,000 shares worth $8.67M.
  • Fayez Sarofim & Co added most to CME Group in Q2 2023, an estimated $45.6M increase.
  • Fayez Sarofim & Co's biggest Q2 2023 reduction was Microsoft, cutting an estimated $152M.
  • Fayez Sarofim & Co fully exited AvalonBay Communities in Q2 2023, selling an estimated $1.33M.
  • Fayez Sarofim & Co's ten largest holdings make up 44% of its $28.6B portfolio in Q2 2023.
  • Fayez Sarofim & Co opened 10 new positions and closed 13 in Q2 2023.
  • Fayez Sarofim & Co's portfolio value fell 0.06% quarter-over-quarter to $28.6B.

Based on Fayez Sarofim & Co's 13F filing for Q2 2023, filed 14 Aug 2023.